Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia

ABSTRACT: Background: There is no effective therapy for the severe acute respiratory syndrome by coronavirus 2 (SARS-CoV2) responsible for the Coronavirus disease 2019 (Covid-19). To date, dexamethasone has shown a decrease in mortality in patients who require oxygen, especially those with invasive...

Full description

Autores:

Jaramillo Arroyave, Daniel
Pinzón, Miguel Alejandro
Ortiz, Santiago
Holguín, Héctor
Betancur, Juan Felipe
Cardona Arango, Doris
Laniado, Henry
Arias Arias, Carolina
Muñoz, Bernardo
Quiceno, Julián
Ramírez, Zoraida

Tipo de recurso:

Article of investigation

Fecha de publicación:

2021

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/42830

Acceso en línea:

https://hdl.handle.net/10495/42830

Palabra clave:

Proteína C-Reactiva
C-Reactive Protein
COVID-19
Dexametasona
Dexamethasone
Relación Dosis-Respuesta a Droga
Dose-Response Relationship, Drug
Esquema de Medicación
Drug Administration Schedule
Productos de Degradación de Fibrina-Fibrinógeno
Fibrin Fibrinogen Degradation Products
Glucocorticoides
Glucocorticoids
Metilprednisolona
Methylprednisolone
SARS-CoV-2
Índice de Severidad de la Enfermedad
Severity of Illness Index
Tasa de Supervivencia
Survival Rate
Resultado del Tratamiento
Treatment Outcome
https://id.nlm.nih.gov/mesh/D002097
https://id.nlm.nih.gov/mesh/D000086382
https://id.nlm.nih.gov/mesh/D003907
https://id.nlm.nih.gov/mesh/D004305
https://id.nlm.nih.gov/mesh/D004334
https://id.nlm.nih.gov/mesh/D005338
https://id.nlm.nih.gov/mesh/D005938
https://id.nlm.nih.gov/mesh/D008775
https://id.nlm.nih.gov/mesh/D000086402
https://id.nlm.nih.gov/mesh/D012720
https://id.nlm.nih.gov/mesh/D015996
https://id.nlm.nih.gov/mesh/D016896

Rights

openAccess

License

https://creativecommons.org/licenses/by/4.0/